PLUREXA
LIVE

Serial Number

97692503

Owner

Plurexa LLC

First Use Date

Apr 12, 2023

Filing Date

Nov 26, 2022

Add to watchlist:

No watchlists yet
View on USPTO

PLUREXA Trademark

Serial Number: 97692503 • Registration: 7509068

PLUREXA is a trademark filed by Plurexa LLC on November 26, 2022. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Plurexa LLC

1209 6th Ave N STE 101
Seattle, WA 98109

Entity Type: 16

Trademark Details

Filing Date

November 26, 2022

Registration Date

September 17, 2024

First Use Anywhere

April 12, 2023

First Use in Commerce

April 12, 2023

Published for Opposition

October 10, 2023

Goods & Services

Cells for scientific and research use; Cells for scientific, laboratory or medical research; Stem cells other than for medical or veterinary purposes; Stem cells, other than for medical or veterinary purposes; Stem cells for research or scientific purposes; Stem cells for research purposes

Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development services in the field of antibodies; Research in the field of cell engineering technology; Research in the field of gene editing technology; Biochemical research; Biochemical research and analysis; Biochemical research and development; Biological research; Biological research and analysis; Biomedical research services; Biotechnology research; Cell culture services for scientific and research purposes, for others; Chemical research; Chemical research and analysis; Chemical research services; Consulting services in the field of pharmaceutical research and development; Culturing of cells for others for scientific research purposes; Genetic testing for scientific research purposes; Pharmaceutical research and development; Pharmaceutical research services; Physics research; Product research; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Scientific research; Scientific research and development; Scientific research consulting; Scientific research for medical purposes in the area of cancerous diseases; Scientific research in the field of genetics and genetic engineering; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 17, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 9, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 9, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 8, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 7, 2024 AITU
USE AMENDMENT FILED
May 4, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
May 4, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 5, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 10, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 10, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 20, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 6, 2023 CNSA
ASSIGNED TO EXAMINER
Sep 6, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 19, 2022 NWOS
NEW APPLICATION ENTERED
Nov 30, 2022 NWAP